id,name,comment,phosphosite,uniprot,PMID,pdb_id29956,Pde3b,"Promotes 14-3-3 binding and increased Pde3b activity (PMID 10454575, 12453887). Pde3b catalyses hydrolysis of cAMP, influencing cAMP-dependent processes. For instance, this deactivates hormone-sensitive lipase and lipolysis in adipocytes.",S272,B2RWU9,"10454575, 12453887",21925,ULK1,"mTORC1 phosphorylates Ulk1 at Ser757, which affects the interaction between Ulk1 and AMPK (PMID 21258367, 21383122). Although there is conflicting evidence about the direction and effect of this interaction, there is a consensus that this prevents autophagy when nutrients are not limiting.",S763,O70405,"21258367, 21383122",2hak32877,PKA,"Protein kinase A (PKA) is stimulated when 1) cAMP binds the PKA regulatory subunits, dissociating them from the catalytic subunits (PKACA), and 2) PDK1 phosphorylates PKACA at T198 (PMID 9488457, 9707564, 12372837). This site is found within the activation loop, generating conformational changes that lead to active PKA.",T198,P05132,"9488457, 9707564, 12372837",4dfy7591,Brf1,"Promotes 14-3-3 binding. This impairs its role in degrading mRNA molecules that contain AU-rich elements. 14-3-3 binding also protects Brf1 from degradation, perhaps to enable rapid mRNA decay once the insulin stimulus is removed (PMID 15538381, 17030608).",S92,P23950,"15538381, 17030608",1rgo6241,HSF1,"In response to growth factors, MAPK phosphorylates HSF1 at S307, which primes GSK3 to phosphorylate at S303 (PMID 8940068). This promotes 14-3-3 binding, sequestering HSF1 in the cytoplasm and thus repressing its transcriptional activity (PMID 12917326). This represses the heat shock response during processes stimulated by growth-factors, such as cellular proliferation.",S303,P38532,"8940068, 12917326",2ldu6242,HSF1,"In response to growth factors, MAPK phosphorylates HSF1 at S307, which primes GSK3 to phosphorylate at S303 (PMID 8940068). This promotes 14-3-3 binding, sequestering HSF1 in the cytoplasm and thus repressing its transcriptional activity (PMID 12917326). This represses the heat shock response during processes stimulated by growth-factors, such as cellular proliferation.",S307,P38532,"8940068, 12917326",2ldu6246,HSF1,"In response to stresses such as heat shock, mTORC1 phosphorylates HSF1 at S326, leading to the upregulation of heat-shock proteins (e.g. Hsp70) to combat cellular stress (PMID 22768106).",S326,P38532,22768106,2ldu1143,Rps6,"p70S6K phosphorylates RPS6 (S6), a component in the 40S ribosomal subunit, at several sites, including S236 and S240 (PMID 1939282). Some studies support this results in the selective translation of a subset of mRNAs, 5'TOP mRNAs, (e.g., PMID 9218810), this remains controversial (e.g., PMID 11972328, 16166381). There is also evidence that S236 phosphorylation promotes binding to the 7-methylguanosine cap-binding complex, to initiate translation (PMID 17360704), but studies have also shown that phosphorylation reduces protein synthesis, slows cell division, and increases cell size (e.g., PMID 16166381). Thus, the physiological outcome of S6 phosphorylation remains unclear.",S236,P62754,1939282,3j161144,Rps6,"p70S6K phosphorylates RPS6 (S6), a component in the 40S ribosomal subunit, at several sites, including S236 and S240 (PMID 1939282). Some studies support this results in the selective translation of a subset of mRNAs, 5'TOP mRNAs, (e.g., PMID 9218810), this remains controversial (e.g., PMID 11972328, 16166381). There is also evidence that S236 phosphorylation promotes binding to the 7-methylguanosine cap-binding complex, to initiate translation (PMID 17360704), but studies have also shown that phosphorylation reduces protein synthesis, slows cell division, and increases cell size (e.g., PMID 16166381). Thus, the physiological outcome of S6 phosphorylation remains unclear.",S240,P62754,1939282,3j1631143,Erk2,"MEK1/2 phosphorylates ERK1/2 within the 'activation lip', on T203/Y205 in ERK1 and T183/Y185 in ERK2 (PMID 1849075, 8444886, 8626767, 7504457). Phosphorylation is favoured first on the tyrosine residue before the threonine residue (PMID 9228083, 1628739). This leads to activation of ERK1/2, enabling regulation of a diverse range of cellular responses to external stimuli (PMID 22569528). Furthermore, ERK1/2 has the ability to autophosphorylate itself at these sites (PMID 8444886, 7504457), but a 'gatekeeper' site prevents this to maintain low basal ERK1/2 activity (PMID 17114285).",T183,P63085,"1849075, 8444886, 8626767, 7504457, 9228083, 1628739, 22569528, 17114285",3r6337331,Erk2,"MEK1/2 phosphorylates ERK1/2 within the 'activation lip', on T203/Y205 in ERK1 and T183/Y185 in ERK2 (PMID 1849075, 8444886, 8626767, 7504457). Phosphorylation is favoured first on the tyrosine residue before the threonine residue (PMID 9228083, 1628739). This leads to activation of ERK1/2, enabling regulation of a diverse range of cellular responses to external stimuli (PMID 22569528). Furthermore, ERK1/2 has the ability to autophosphorylate itself at these sites (PMID 8444886, 7504457), but a 'gatekeeper' site prevents this to maintain low basal ERK1/2 activity (PMID 17114285).",Y185,P63085,"1849075, 8444886, 8626767, 7504457, 9228083, 1628739, 22569528, 17114285",3r637476,Pfkfb2,"There is strong evidence to suggest that PFKFB2 (cardiac PFK-2) is phosphorylated at S469 and S486 by Akt, leading to 14-3-3 binding and increased activity (PMID 9211863, 12853467, 20958264). This elevates levels of its product, fructose-2,6-bisphosphate, which stimulates glycolysis.",S469,P70265,"9211863, 12853467, 20958264",1fbt7477,Pfkfb2,"There is strong evidence to suggest that PFKFB2 (cardiac PFK-2) is phosphorylated at S469 and S486 by Akt, leading to 14-3-3 binding and increased activity (PMID 9211863, 12853467, 20958264). This elevates levels of its product, fructose-2,6-bisphosphate, which stimulates glycolysis.",S486,P70265,"9211863, 12853467, 20958264",1fbt23370,eNOS,"Activates eNOS, reducing its requirement for Ca2+ and increasing production of nitric oxide. This signalling molecule plays a role in numerous processes including vasodilation (PMID 10376603).",S1176,P70313,10376603,3nos24474,GSK3a,"GSK3a/b are unique kinase in that they requires its substrate to be phosphorylated at a residue +4 of the GSK3 target site. The GSK3 domain that binds this 'priming site' is occupied by the GSK3 N-terminus when S9/21 (GSK3b/a) is phosphorylated by Akt (PMID 11430833). This leads to disrupted GSK3 activity (PMID 8524413). This not only derepresses glycogen synthesis (PMID 8816781), for which GSK3 is named, but influences a wide range of cellular processes (reviewed in PMID 11579232).",S21,Q2NL51,"11430833, 8524413, 8816781, 11579232",2ow31212,p90RSK,"MAPK/ERK phosphorylates p90(RSK) on several residues, including S363 (PMID 9430688). This residue is found within the N-terminal kinase domain, contributing to the activation of p90(RSK).",S363,Q3TIM6,9430688,3943,TAK1,"Protein kinase A phosphorylates TAK1 on S439. This allows cAMP/PKA-dependent signals, such as prostaglandin E2, to enhance downstream signalling pathways, including MAPK and NF-Kb, subsequently promoting osteoclast differentiation (PMID 15647289). This is in concordance with the role that TAK1 plays in directing differentiation away from adipogenesis (PMID 12598905).",S439,Q3TXG1,15647289,23681,Irs1,"Following insulin stimulation, S522 of IRS-1 is phosphorylated by S6K (PMID 16914728), which reduces tyrosine phosphorylation of IRS-1 (PMID 17579213). This provides a feedback loop to regulate insulin signalling.",S526,Q543V3,"16914728, 17579213",37636,Irs1,"Upon insulin stimulation, IRS-1 is phosphorylated by the insulin receptor at numerous tyrosine residues. These serve as docking sites for SH2-binding proteins. From the phosphosites shown, Y680 (and Y460 to some extent) bind the p85 subunit of PI3K (PMID 7504175), mediating the PI3K/Akt pathway; Y891 binds GRB2 to activate Ras/MAPK (PMID 7504175, 8196603); Y1173 binds SHPTP2 to also activate Ras/MAPK (PMID 7504175, 7935386). Thus, IRS-1 acts as a divergence point, stimulating multiple signalling pathways in response to insulin.",Y891,Q543V3,"7504175, 8196603, 7935386",37639,Irs1,"Upon insulin stimulation, IRS-1 is phosphorylated by the insulin receptor at numerous tyrosine residues. These serve as docking sites for SH2-binding proteins. From the phosphosites shown, Y680 (and Y460 to some extent) bind the p85 subunit of PI3K (PMID 7504175), mediating the PI3K/Akt pathway; Y891 binds GRB2 to activate Ras/MAPK (PMID 7504175, 8196603); Y1173 binds SHPTP2 to also activate Ras/MAPK (PMID 7504175, 7935386). Thus, IRS-1 acts as a divergence point, stimulating multiple signalling pathways in response to insulin.",Y460,Q543V3,"7504175, 8196603, 7935386",37640,Irs1,"Upon insulin stimulation, IRS-1 is phosphorylated by the insulin receptor at numerous tyrosine residues. These serve as docking sites for SH2-binding proteins. From the phosphosites shown, Y608 (and Y460 to some extent) bind the p85 subunit of PI3K (PMID 7504175), mediating the PI3K/Akt pathway; Y891 binds GRB2 to activate Ras/MAPK (PMID 7504175, 8196603); Y1173 binds SHPTP2 to also activate Ras/MAPK (PMID 7504175, 7935386). Thus, IRS-1 acts as a divergence point, stimulating multiple signalling pathways in response to insulin.",Y608,Q543V3,"7504175, 8196603, 7935386",37643,Irs1,"Upon insulin stimulation, IRS-1 is phosphorylated by the insulin receptor at numerous tyrosine residues. These serve as docking sites for SH2-binding proteins. From the phosphosites shown, Y608 (and Y460 to some extent) bind the p85 subunit of PI3K (PMID 7504175), mediating the PI3K/Akt pathway; Y891 binds GRB2 to activate Ras/MAPK (PMID 7504175, 8196603); Y1173 binds SHPTP2 to also activate Ras/MAPK (PMID 7504175, 7935386). Thus, IRS-1 acts as a divergence point, stimulating multiple signalling pathways in response to insulin.",Y1171,Q543V3,"7504175, 8196603, 7935386",37334,InsR,"Upon binding insulin, the insulin receptor phosphorylates itself on mouse Y1175, Y1179, Y1180 (human Y1185, Y1189, and Y1190), both in vitro and in vivo (PMID 2449432, 3166375, 2158467), leading to its activation (PMID 1658004) and stimulation of insulin-responsive pathways, such as glucose uptake in fat and muscle.",Y1175,Q60751,"2449432, 3166375, 2158467, 1658004",1m7n37335,InsR,"Upon binding insulin, the insulin receptor phosphorylates itself on mouse Y1175, Y1179, Y1180 (human Y1185, Y1189, and Y1190), both in vitro and in vivo (PMID 2449432, 3166375, 2158467), leading to its activation (PMID 1658004) and stimulation of insulin-responsive pathways, such as glucose uptake in fat and muscle.",Y1179,Q60751,"2449432, 3166375, 2158467, 1658004",1m7n37336,InsR,"Upon binding insulin, the insulin receptor phosphorylates itself on mouse Y1175, Y1179, Y1180 (human Y1185, Y1189, and Y1190), both in vitro and in vivo (PMID 2449432, 3166375, 2158467), leading to its activation (PMID 1658004) and stimulation of insulin-responsive pathways, such as glucose uptake in fat and muscle.",Y1180,Q60751,"2449432, 3166375, 2158467, 1658004",1m7n4944,Grb10,"Enhances stability of Grb10. This reduces signalling through insulin receptor or by influencing mTORC1 instead (PMID 21659604, 21659605, 24746805). Nevertheless, this phosphorylation site leads to feedback regulation of insulin signalling.",S503,Q60760,"21659604, 21659605, 24746805",3m7f3081,Akt,"Found in C-terminal hydrophobic motif. Phosphorylation at this site stimulates Akt activity (PMID 9445477).",S474,Q60823,9445477,1p6s31272,Akt,"Found in activation loop of the kinase domain. Primes Akt for second phosphorylation (at S474) for complete activation (PMID 15718470).",T309,Q60823,15718470,1p6s13766,Eif4ebp1,"Phosphorylation at several sites by mTORC1 (T36, T45, and T69, then S64) causes 4E-BP1 to disocciate from eIF4E. This enables eIF4E to bind the 5' cap of mRNAs, resulting in the initiation of translation (PMID 10779345).",S64,Q60876,10779345,3m9333654,Eif4ebp1,"Phosphorylation at several sites by mTORC1 (T36, T45, and T69, then S64) causes 4E-BP1 to disocciate from eIF4E. This enables eIF4E to bind the 5' cap of mRNAs, resulting in the initiation of translation (PMID 10779345).",T36,Q60876,10779345,3m9333657,Eif4ebp1,"Phosphorylation at several sites by mTORC1 (T36, T45, and T69, then S64) causes 4E-BP1 to disocciate from eIF4E. This enables eIF4E to bind the 5' cap of mRNAs, resulting in the initiation of translation (PMID 10779345).",T45,Q60876,10779345,3m9311430,TSC2,"Akt phosphorylates TSC2 on several sites, including S939, S981 and T1423/62 (PMID 12150915, 12172553, 16636147). Whilst there is conflicting evidence about whether its interaction with binding partner TSC1 is affected (PMID 16636147, 12167664), studies suggest phosphorylation promotes 14-3-3 binding (PMID 12438239, 16636147), cytoplasmic localisation (PMID 16636147), and ultimately its degradation (PMID 12172553, 12167664). This derepresses mTORC1 activity, promoting protein and lipid synthesis in response to mitogenic and nutrient stimuli.",S981,Q61037,,3brw11441,TSC2,"Akt phosphorylates TSC2 on several sites, including S939, S981 and T1423/62 (PMID 12150915, 12172553, 16636147). Whilst there is conflicting evidence about whether its interaction with binding partner TSC1 is affected (PMID 16636147, 12167664), studies suggest phosphorylation promotes 14-3-3 binding (PMID 12438239, 16636147), cytoplasmic localisation (PMID 16636147), and ultimately its degradation (PMID 12172553, 12167664). This derepresses mTORC1 activity, promoting protein and lipid synthesis in response to mitogenic and nutrient stimuli.",S939,Q61037,,3brw33125,TSC2,"Akt phosphorylates TSC2 on several sites, including S939, S981 and T1443/1465 (PMID 12150915, 12172553, 16636147). Whilst there is conflicting evidence about whether its interaction with binding partner TSC1 is affected (PMID 16636147, 12167664), studies suggest phosphorylation promotes 14-3-3 binding (PMID 12438239, 16636147), cytoplasmic localisation (PMID 16636147), and ultimately its degradation (PMID 12172553, 12167664). This derepresses mTORC1 activity, promoting protein and lipid synthesis in response to mitogenic and nutrient stimuli.",T1466,Q61037,,3brw1816,Mekk3,"SGK1 phosphorylates MEKK3 (MAP3K3) on S337 (and S166), reducing its kinase activity (PMID 12761204). Since MEKK3 regulates the stress-activated (SAPK) and mitogen-activated (MAPK) protein kinase pathways, this provides a way for SGK1 to turn off these pathways, enabling cross-talk between kinase signalling pathways.",S337,Q61084,12761204,2jrh17539,NHE1,"NHE1 is phosphorylated at this site by p90(RSK). Promotes 14-3-3 binding (PMID 11279064), leading to increased Na+/H+ exchange and cell alkalinisation (PMID 10400637). Whilst this has been shown to exacerbate myocardial ischemia and reperfusion injury (PMID 16717153), it may also be necessary for cell cycle progression (PMID 19622752).",S707,Q61165,10400637,2e3026140,BAD,"In a PKC-dependent manner, p90RSK phosphorylates this site. This promotes14-3-3 binding, blocking BAD from heterodimerising with Bcl-XL, thus promoting cell survival and inhibiting apoptosis (PMID 8929531, 10574959).",S112,Q61337,"8929531, 10574959",2bzw26145,BAD,"Promotes 14-3-3 binding preventing BAD from heterodimerising with Bcl-XL, promoting cell survival and inhibiting apoptosis (PMID 8929531, 9346240).",S136,Q61337,"8929531, 9346240",2bzw12994,SOS1,"MAP kinase (MAPK) phosphorylates SOS1 on several sites, including S1178, S1183, S1197, which causes disassociation of the Sos1-Grb2 complex (PMID 8816480). Since Sos1-Grb2 connects receptor tyrosine kinases to Ras and MAPK downstream, this serves as a feedback mechanism for Ras/MAPK signalling (e.g., PMID 7829473).",S1179,Q62245,8816480,1pms12995,SOS1,"MAP kinase (MAPK) phosphorylates SOS1 on several sites, including S1178, S1183, S1197, which causes disassociation of the Sos1-Grb2 complex (PMID 8816480). Since Sos1-Grb2 connects receptor tyrosine kinases to Ras and MAPK downstream, this serves as a feedback mechanism for Ras/MAPK signalling (e.g., PMID 7829473).",S1183,Q62245,8816480,1pms13015,SOS1,"MAP kinase (MAPK) phosphorylates SOS1 on several sites, including S1178, S1183, S1197, which causes disassociation of the Sos1-Grb2 complex (PMID 8816480). Since Sos1-Grb2 connects receptor tyrosine kinases to Ras and MAPK downstream, this serves as a feedback mechanism for Ras/MAPK signalling (e.g., PMID 7829473).",S1196,Q62245,8816480,1pms4497,Ndrg1,"SGK kinases phosphorylate T328, S330, T346, T356, and T366 of NDRG1 (the latter three found within a triple 10-residue repeat sequence) (PMID 15461589, 20416281). This primes NDRG1 for phosphorylation by GSK3 (PMID 15461589). Phosphorylation of NDRG1 influences its role in stress responses, such as the suppression of NF-Kb signalling and CXC chemokine production (PMID 20416281).",S330,Q62433,"15461589, 20416281",2xmr31569,Ndrg1,"SGK kinases phosphorylate T328, S330, T346, T356, and T366 of NDRG1 (the latter three found within a triple 10-residue repeat sequence) (PMID 15461589, 20416281). This primes NDRG1 for phosphorylation by GSK3 (PMID 15461589). Phosphorylation of NDRG1 influences its role in stress responses, such as the suppression of NF-Kb signalling and CXC chemokine production (PMID 20416281).",T366,Q62433,"15461589, 20416281",2xmr33117,Erk1,"MEK1/2 phosphorylates ERK1/2 within the 'activation lip', on T203/Y205 in ERK1 and T183/Y185 in ERK2 (PMID 1849075, 8444886, 8626767, 7504457). Phosphorylation is favoured first on the tyrosine residue before the threonine residue (PMID 9228083, 1628739). This leads to activation of ERK1/2, enabling regulation of a diverse range of cellular responses to external stimuli (PMID 22569528). Furthermore, ERK1/2 has the ability to autophosphorylate itself at these sites (PMID 8444886, 7504457), but a 'gatekeeper' site prevents this to maintain low basal ERK1/2 activity (PMID 17114285).",T203,Q63844,"1849075, 8444886, 8626767, 7504457, 9228083, 1628739, 22569528, 17114285",4qtb37449,Erk1,"MEK1/2 phosphorylates ERK1/2 within the 'activation lip', on T203/Y205 in ERK1 and T183/Y185 in ERK2 (PMID 1849075, 8444886, 8626767, 7504457). Phosphorylation is favoured first on the tyrosine residue before the threonine residue (PMID 9228083, 1628739). This leads to activation of ERK1/2, enabling regulation of a diverse range of cellular responses to external stimuli (PMID 22569528). Furthermore, ERK1/2 has the ability to autophosphorylate itself at these sites (PMID 8444886, 7504457), but a 'gatekeeper' site prevents this to maintain low basal ERK1/2 activity (PMID 17114285).",Y204,Q63844,"1849075, 8444886, 8626767, 7504457, 9228083, 1628739, 22569528, 17114285",4qtb8828,Eif4b,"p70S6K phosphorylates Ei4b at this site, which promotes association with eIF3 scaffold in the translation preinitiation complex. Here, eIF4A enhances the helicase activity of eIF4A, melting inhibitory secondary structures in the 5'UTR of mRNAs. This enables the 40S ribosomal subunit to bind and initiate translation (PMID 15071500, 16286006).",S422,Q8BGD9,"15071500, 16286006",2j7632613,Sin1,"Akt phosphorylates SIN1, a component of the mTORC2 complex. This activates mTORC2 - amongst its substrates is Akt, thus potentiating a feed-forward signalling loop (PMID 23684622).",T86,Q8BKH7,23684622,3voq19782,p70S6K,"mTORC1 phosphorylates S6K-p70 at T412 (PMID 7489717, 7545671), found within a hydrophobic motif downstream of the catalytic domain. This its phosphorylation of 40S ribosomal protein S6, to activate protein synthesis.",S452,Q8BSK8,"7489717, 7545671, 9632736",4l4510125,AS160,"Promotes 14-3-3 binding (although T649 is primary binding site). Disrupts GTPase-activating (GAP) function of AS160 and promotes translocation of GLUT4 glucose transporter to the plasma membrane, increasing glucose uptake (PMID 12637568, 16880201, 17617058).",S324,Q8BYJ6,"12637568, 17617058",3qyb10128,AS160,"Promotes 14-3-3 binding (although T649 is primary binding site). Disrupts GTPase-activating (GAP) function of AS160 and promotes translocation of GLUT4 glucose transporter to the plasma membrane, increasing glucose uptake (PMID 12637568, 16880201, 17617058).",S348,Q8BYJ6,"12637568, 17617058",3qyb10126,AS160,"Promotes 14-3-3 binding (although T649 is primary binding site). Disrupts GTPase-activating (GAP) function of AS160 and promotes translocation of GLUT4 glucose transporter to the plasma membrane, increasing glucose uptake (PMID 12637568, 16880201, 17617058).",S595,Q8BYJ6,"12637568, 19897488",3qyb32814,AS160,"Promotes 14-3-3 binding (although T649 is primary binding site). Disrupts GTPase-activating (GAP) function of AS160 and promotes translocation of GLUT4 glucose transporter to the plasma membrane, increasing glucose uptake (PMID 12637568, 16880201, 17617058).",T649,Q8BYJ6,"12637568, 16880201, 17617058",3qyb11092,MSK1,"The mitogen- and stress-activated kinase 1 (MSK1) is initially phosphorylated by p38 MAPK and ERK1 (PMID 11994045, 15568999), including on residue T645 (human T581), this enables MSK1 to autophosphorylate: the C-terminal kinase domain phosphorylates itself at several sites, including the hydrophobic motif at S375 (human S376). This activates the N-terminal kinase domain, enabling MSK1 to phosphorylate its substrates (PMID 15568999). This enables the cell to respond to both growth factors and cellular stress through the same kinase (e.g., PMID 9687510).",S375,Q8C050,"11994045, 15568999, 9687510",3kn510659,Hsl,"PKA phosphorylates HSL on several residues. This results in the activation of HSL, promoting lipolysis and thus mobilisation of energy stores during exercise or starvation (PMID 9417067, 19018281).",S632,Q8CDI9,"9417067, 19018281",10665,Hsl,"AMPK phosphorylates mouse S559 (rat S565) (PMID 2537200). Phosphorylation of S559 is present in the 'basal' state (in the absence of lipolytic stimuli) and has little effect on HSL activity (PMID 2537200, 15033481, 15308678). There is some evidence that it reduces phosphorylation at mouse S557 (rat S563) by PKA (PMID 16188906, 2537200, 2165906), which is needed for HSL activity in mediating lipolysis (PMID 9636039).",S555,Q8CDI9,2537200,9506,Plin1,"Protein kinase A phosphorylates Plin1 (perilipin A) at S492, which promotes access of lipases to lipid droplets in adipocytes, leading to lipid droplet breakdown and lipolysis (PMID 16488886, 17114792). This serves to mobilise energy during fasting and exercise.",S492,Q8CGN5,"16488886, 17114792",8254,Edc3,"Promotes 14-3-3 binding, which impairs its role in mRNA decay and translation repression at p-bodies (PMID 20051463). This provides one avenue for insulin to increase protein synthesis.",S161,Q8K2D3,20051463,3d3j6505,Pras40,"Akt phosphorylates PRAS40 at T247 (PMID 12524439, 17386266, 17277771), which promotes mTORC1 to phosphorylate PRAS40 at multiple sites, including S184 (PMID 20138985, 17517883). Together, these phosphorylation events cause PRAS40 to dissociate from mTORC1 and bind 14-3-3. Combined with Akt-mediated TSC2 phosphorylation, this results in mTORC1 activation.",S159,Q9D1F4,"12524439, 17386266, 17277771, 17517883, 20138985",32018,Pras40,"Akt phosphorylates PRAS40 at T247 (PMID 12524439, 17386266, 17277771), which promotes mTORC1 to phosphorylate PRAS40 at multiple sites, including S184 (PMID 20138985, 17517883). Together, these phosphorylation events cause PRAS40 to dissociate from mTORC1 and bind 14-3-3. Combined with Akt-mediated TSC2 phosphorylation, this results in mTORC1 activation.",T270,Q9D1F4,"12524439, 17386266, 17277771, 17517883, 20138985",11843,mTOR,"Upon activation, mTOR autophosphorylates itself on S2481 (PMID 10702316), being observed in both complexes mTORC1 and mTORC2 (PMID 20022946). Although diagonistic of mTOR activity, the physiological significance of this autophosphorylation site remains elusive.",S2481,Q9JLN9,"10702316, 20022946",2gaq11851,mTOR,"Originally considered an Akt target (PMID 10910062, 10567225), more recent evidence suggests that S2448 is actually phosphorylated by p70-S6K (PMID 15899889, 15905173). This presents a feedback loop, although its function has not been elucidated. Since S2448 lies within the repressor domain, it has been speculated that phosphorylation at this site represses mTOR activity (PMID 10910062), but does not affect mTORC1 complex formation (PMID 19145465).",S2448,Q9JLN9,"10910062, 10567225, 15899889, 15905173, 19145465",2gaq32167,Ndrg2,"SGK kinases phosphorylate T330, S332, and T348 of NDRG2 - there is some evidence that this primes NDRG2 for phosphorylation by GSK3 (PMID 15461589). The functional consequences of this have not been well-studied.",T330,Q9QYG0,15461589,2qmq32169,Ndrg2,"SGK kinases phosphorylate T330, S332, and T348 of NDRG2 - there is some evidence that this primes NDRG2 for phosphorylation by GSK3 (PMID 15461589). The functional consequences of this have not been well-studied.",T348,Q9QYG0,15461589,2qmq4288,GSK3b,"GSK3a/b are unique kinase in that they requires its substrate to be phosphorylated at a residue +4 of the GSK3 target site. The GSK3 domain that binds this 'priming site' is occupied by the GSK3 N-terminus when S9/21 (GSK3b/a) is phosphorylated by Akt (PMID 11430833). This leads to disrupted GSK3 activity (PMID 8524413). This not only derepresses glycogen synthesis (PMID 8816781), for which GSK3 is named, but influences a wide range of cellular processes (reviewed in PMID 11579232).",S9,Q9WV60,"11430833, 8524413, 8816781, 11579232",4nm04508,Foxo3a,"Promotes 14-3-3 binding and subsequent export from the nucleus. This prevents its regulation of target genes, including those involved in apoptosis (PMID 10102273, 11864996).",S252,Q9WVH4,"10102273, 11864996",2uzk5572,Gys,"GSK3 phosphorylates Gys at consecutive serines (S641, S645, S649, S653) in a C->N direction (PMID 6249596, 6772446). Once S641 is phosphorylated, Gys activity is reduced, now depending on glucose-6-phosphate for allosteric activation (PMID 7759494, 8226927). Upon insulin stimulation, GSK3 is inhibited, de-repressing Gys and thus stimulating glycogen synthesis (PMID 14745035, 22248338).",S641,Q9Z1E4,"6249596, 6772446, 7759494, 8226927, 14745035, 22248338",4kqm5575,Gys,"GSK3 phosphorylates Gys at consecutive serines (S641, S645, S649, S653) in a C->N direction (PMID 6249596, 6772446). Once S641 is phosphorylated, Gys activity is reduced, now depending on glucose-6-phosphate for allosteric activation (PMID 7759494, 8226927). Upon insulin stimulation, GSK3 is inhibited, de-repressing Gys and thus stimulating glycogen synthesis (PMID 14745035, 22248338).",S649,Q9Z1E4,"6249596, 6772446, 7759494, 8226927, 14745035, 22248338",4kqm